Myomo, Inc.

MYO ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-15.6M $-6.2M $-8.1M $-10.7M $-10.4M $-11.6M $-10.7M $-10.3M
Depreciation & Amortization — — — — — — — —
Depreciation $859.4K $205.9K $164.3K $192.8K $146.0K $105.4K $95.1K $69.7K
Amortization — — — — — — — —
Stock-Based Compensation $2.1M $874.4K $1.1M $1.2M $1.1M $614.3K $908.0K $814.7K
Net Cash from Operating Activities $-14.5M $-3.3M $-6.2M $-10.2M $-9.5M $-9.0M $-10.3M $-9.6M
Investing Activities
Capital Expenditures $1.7M $1.4M $145.8K $111.8K $326.5K $45.8K $52.0K $126.9K
Business Acquisitions — — $0 $199.0K $0 — — —
Net Cash from Investing Activities $-7.1M $260.0K $-2.0M $-310.8K $-326.5K $-45.8K $-52.0K $-126.9K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $11.4M $20.9M $9.7M $376.9K $13.2M $16.8M $8.3M $3.3M
Net Change in Cash $-10.0M $17.9M $1.5M $-10.2M $3.3M $7.7M $-2.1M $-6.4M
Free Cash Flow $-16.3M $-4.7M $-6.3M $-10.3M $-9.9M $-9.1M $-10.4M $-9.7M
← Newer Page 1 of 2 Older →